Burcon NutraScience Engages Liolios Group to Lead New Investor Relations Program

Burcon NutraScience Engages Liolios Group to Lead New Investor Relations

Company at Inflection Point in Commercial Roll-out of Breakthrough in Plant
Protein Quality

VANCOUVER, British Columbia, April 8, 2013 (GLOBE NEWSWIRE) -- Burcon
NutraScience Corporation (TSX:BU) (Nasdaq:BUR), a world leader in plant
protein extraction and purification technologies, has engaged Liolios Group to
lead a new investor relations and financial communications campaign.

"With our manufacturing and marketing partner, Archer Daniels Midland,
initiating production and sales of our patented soy-based CLARISOY™ protein,
and our new Peazazz™ pea protein semi-works facility on track to begin
commercial-level production in June, Burcon has arrived at a turning point in
its development," said Johann Tergesen, president and COO of Burcon.

These accomplishments, supported by recent industry awards and key U.S.
patents, have propelled Burcon into an industry-leading position as a
developer of premium plant protein ingredients that demonstrate exceptional
clarity, solubility, clean taste, sustainability, manufacturing scalability
and value delivered to a growing demographic of health-conscious consumers.

"Given these compelling factors, we believe the time has come to engage an
experienced team of investor relations professionals to help us communicate
our story to the financial community," continued Tergesen. "Liolios Group
brings a proven track record of helping companies like Burcon enhance its
shareholder value by delivering the right message to the right audience, and
building high quality, long-term relationships in the investment community."

Liolios Group will work closely with Burcon's management to refine and deliver
the company's message, and make introductions to key investors and influencers
in the financial community. They will also assist the company in scheduling
road shows and financial conferences over the next 12 months.

To arrange for a call or meeting with management, contact John MacLennan at
(416) 644-8688 or john@liolios.com.

About Liolios Group Inc.

Liolios Group is a highly selective and comprehensive investor relations firm
specializing in micro to mid-cap companies. The firm aims to deliver superior
performance in corporate messaging and positioning, investor awareness,
analyst and financial press coverage and capital attraction.Founded in 1999,
Liolios Group executives have extensive experience in financial and
investments and represent clients in a wide range of industries, including
life sciences/healthcare, consumer/internet retail, business services,
digital, media/software, clean technology, technology, natural resources and
special situations.

For more information about Liolios Group, visit www.liolios.com.

About Burcon NutraScience Corporation

Burcon NutraScience is a leader in nutrition, health and wellness in the field
of functional plant proteins. The company has developed a portfolio of
composition, application, and process patents originating from a core protein
extraction and purification technology.Burcon has developed: CLARISOY™ soy
protein - now licensed to Archer Daniels Midland Company - which offers
clarity and high-quality protein nutrition for low pH beverage systems and
exceptionally clean flavor at any pH; Peazazz™ a uniquely soluble and
clean-tasting pea protein; and Puratein®, Supertein™ and Nutratein™ are canola
protein isolates with unique functional and nutritional attributes. For more
information about the company, visitwww.burcon.ca.

CLARISOY is a trademark of Archer Daniels Midland Company.

The TSX has not reviewed and does not accept responsibility for the adequacy
of the content of the information contained herein. This press release
contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results, performances,
prospects and opportunities to differ materially from those expressed or
implied by such forward-looking statements. All statements other than
statements of historical fact included in this release are forward-looking
statements, including, without limitation, statements regarding plans and
timing for the introduction or enhancement of our products, statements about
future market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release. There can
be no assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those anticipated in
such statements or information. Important factors that could cause actual
results to differ materially from Burcon's plans and expectations include the
actual results of marketing activities, adverse general economic, market or
business conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with securities
regulators and stock exchanges, including in the section entitled "Risk
Factors" in Burcon's annual information form dated June 25, 2012. Any
forward-looking statement or information only speaks as of the date on which
it was made and, except as may be required by applicable securities laws,
Burcon disclaims any intent or obligation to update any forward-looking
statement, whether as a result of new information, future events or otherwise.
Although Burcon believes that the assumptions inherent in the forward-looking
statements are reasonable, forward-looking statements are not guarantees of
future performance and accordingly undue reliance should not be put on such.

CONTACT: Media & Industry Contact:
         Michael Kirwan
         Director, Corporate Development
         Burcon NutraScience Corporation
         (604) 733-0896
         (888) 408-7960 toll-free
         Investor Relations Contact:
         John MacLennan
         Tel (416) 644.8688 or (949) 574-3860
Press spacebar to pause and continue. Press esc to stop.